Literature DB >> 23990676

Should glucose-sparing prescriptions be expected to reduce the cardiovascular risk of peritoneal dialysis patients?

Rajnish Mehrotra1, Ian H de Boer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23990676      PMCID： PMC3810097          DOI： 10.1681/ASN.2013080823

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  28 in total

1.  Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.

Authors:  W N Suki; R Zabaneh; J L Cangiano; J Reed; D Fischer; L Garrett; B N Ling; S Chasan-Taber; M A Dillon; A T Blair; S K Burke
Journal:  Kidney Int       Date:  2007-08-29       Impact factor: 10.612

Review 2.  Metabolic consequences of peritoneal dialysis.

Authors:  John Burkart
Journal:  Semin Dial       Date:  2004 Nov-Dec       Impact factor: 3.455

3.  Impact of peritoneal absorption of glucose on appetite, protein catabolism and survival in CAPD patients.

Authors:  S J Davies; L Russell; J Bryan; L Phillips; G I Russell
Journal:  Clin Nephrol       Date:  1996-03       Impact factor: 0.975

4.  Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.

Authors:  Ramón Paniagua; Dante Amato; Edward Vonesh; Ricardo Correa-Rotter; Alfonso Ramos; John Moran; Salim Mujais
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

5.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

6.  The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

Authors:  A Besarab; W K Bolton; J K Browne; J C Egrie; A R Nissenson; D M Okamoto; S J Schwab; D A Goodkin
Journal:  N Engl J Med       Date:  1998-08-27       Impact factor: 91.245

7.  Effect of dialysis dose and membrane flux in maintenance hemodialysis.

Authors:  Garabed Eknoyan; Gerald J Beck; Alfred K Cheung; John T Daugirdas; Tom Greene; John W Kusek; Michael Allon; James Bailey; James A Delmez; Thomas A Depner; Johanna T Dwyer; Andrew S Levey; Nathan W Levin; Edgar Milford; Daniel B Ornt; Michael V Rocco; Gerald Schulman; Steve J Schwab; Brendan P Teehan; Robert Toto
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

8.  Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients.

Authors:  Florian Kronenberg; Arno Lingenhel; Ulrich Neyer; Karl Lhotta; Paul König; Martin Auinger; Martin Wiesholzer; Helene Andersson; Hans Dieplinger
Journal:  Kidney Int Suppl       Date:  2003-05       Impact factor: 10.545

9.  Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients.

Authors:  Philip K T Li; Bruce F Culleton; Amaury Ariza; Jun-Young Do; David W Johnson; Mauricio Sanabria; Ty R Shockley; Ken Story; Andrey Vatazin; Mauro Verrelli; Alex W Yu; Joanne M Bargman
Journal:  J Am Soc Nephrol       Date:  2013-08-15       Impact factor: 10.121

10.  Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.

Authors:  Rex L Jamison; Pamela Hartigan; James S Kaufman; David S Goldfarb; Stuart R Warren; Peter D Guarino; J Michael Gaziano
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272
View more
  1 in total

1.  Renal Replacement Therapy: Purifying Efficiency of Automated Peritoneal Dialysis in Diabetic versus Non-Diabetic Patients.

Authors:  Nicanor Vega-Diaz; Fayna Gonzalez-Cabrera; Silvia Marrero-Robayna; Raquel Santana-Estupiñan; Roberto Gallego-Samper; Fernando Henriquez-Palop; Patricia Perez-Borges; José Carlos Rodriguez-Perez
Journal:  J Clin Med       Date:  2015-07-22       Impact factor: 4.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.